Raymond James Financial Services Advisors’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,275
Closed -$392K 3447
2022
Q3
$392K Buy
14,275
+861
+6% +$21.3K ﹤0.01% 2400
2022
Q2
$309K Sell
13,414
-24,455
-65% -$571K ﹤0.01% 2565
2022
Q1
$826K Sell
37,869
-12,847
-25% -$267K ﹤0.01% 2074
2021
Q4
$1.08M Sell
50,716
-163
-0.3% -$3.42K ﹤0.01% 1935
2021
Q3
$1.06M Sell
50,879
-2,186
-4% -$47.7K ﹤0.01% 1911
2021
Q2
$1.22M Sell
53,065
-18,661
-26% -$429K ﹤0.01% 1809
2021
Q1
$1.58M Sell
71,726
-66,019
-48% -$1.53M ﹤0.01% 1540
2020
Q4
$2.57M Buy
137,745
+17,915
+15% +$294K 0.01% 1157
2020
Q3
$1.74M Buy
119,830
+74,999
+167% +$954K 0.01% 1240
2020
Q2
$502K Buy
44,831
+32,024
+250% +$360K ﹤0.01% 1920
2020
Q1
$128K Buy
+12,807
New +$179K ﹤0.01% 2187

Other funds holding CHNG

Raymond James Financial Services Advisors's CHNG Position: Q4 2022 in Review

Raymond James Financial Services Advisors sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 14,275 shares — an estimated $392K sold.

Raymond James Financial Services Advisors first reported a position in CHNG in Q1 2020 and held it in 11 quarters. The position peaked at $2.57M in Q4 2020. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Raymond James Financial Services Advisors reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 14,275 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $392K.
  • Raymond James Financial Services Advisors first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Raymond James Financial Services Advisors's Change Healthcare Inc. Common Stock position peaked at $2.57M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.